FDA-approved epilepsy drug may help reverse osteoarthritis damage
Researchers at Yale have identified a promising new approach to osteoarthritis that could do more than simply ease pain. The epilepsy drug lacosamide appears to block a protein involved in both pain signaling and cartilage destruction, helping damaged joints shift back toward repair in preclinical studies.
We haven't written up this one. ScienceDaily Health has the full story — the link below goes straight to it.
Also reported by 1 other outlet
- FDA-approved epilepsy drug may help reverse osteoarthritis damage sciencedaily.com
